- 主题
- 376
- 您的身份
- 病友
- 就诊医院
- 北京协和
- 病理报告
- 滤泡性淋巴瘤1-2级
- 目前状态
- 康复10-20年
参加活动:0 次 组织活动:0 次
您的身份病友
病理报告滤泡性淋巴瘤1-2级
就诊医院北京协和
目前状态康复10-20年
最后登录2024-11-24
|
发表于 2023-1-1 13:39:01
|
显示全部楼层
来自: 中国北京
How is venetoclax + obinutuzumab therapy for CLL given?
Cycle 1 (Days 1-28)
Day 1: Obinutuzumab 100 mg intravenous (I.V.) infusion over four hours
Day 2: Obinutuzumab 900 mg IV over four or more hours (4 hours if no infusion reactions, more time if reactions occur)
Day 8: Obinutuzumab 1000 mg IV over four or more hours
Day 15: Obinutuzumab 1000 mg IV over four or more hours
Day 22: Venetoclax 20 mg (two 10 mg tablets) by mouth once daily, every day for seven days
Cycle 2 (Begins on Day 29; cycle length is 28 days)
Day 1: Obinutuzumab 1000 mg IV over four or more hours
Day 1: Venetoclax 50 mg by mouth once daily, every day for seven days
Day 8: Venetoclax 100 mg by mouth once daily, every day for seven days
Day 15: Venetoclax 200 mg (two 100 mg tablets) by mouth once daily, every day for seven days
Day 22: Venetoclax 400 mg (four 100 mg tablets) by mouth once daily, every day for seven days
Cycles 3-6 (Begins on Day 57; cycle length is 28 days)
Day 1: Obinutuzumab 1000 mg IV over four or more hours
Venetoclax 400 mg (four 100 mg tablets) by mouth once daily, every day
Cycles 7-12 (cycle length is 28 days)
Venetoclax 400 mg (four 100 mg tablets) by mouth once daily, every day
After cycle 12 is finished, ventoclax is stopped and the patient is monitored off all treatment. |
|